| 臺大學術典藏 |
2022-02-22T05:34:08Z |
Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy
|
Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.; Hsu C.-H.; Lin Z.-Z.; Shao Y.-Y.; Lu L.-C.; Liu T.-H.; CHIEN-HUNG CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2022-02-21T02:51:54Z |
Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy
|
YING-CHUN SHEN; Yeh C.-P.; Jeng Y.-M.; Hsu C.; Hsu C.-H.; Lin Z.-Z.; Shao Y.-Y.; Lu L.-C.; Liu T.-H.; Chen C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-02-21T02:04:36Z |
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|
Ou D.-L.; Chen C.-W.; Hsu C.-L.; Chung C.-H.; Feng Z.-R.; Lee B.-S.; ANN-LII CHENG; Yang M.-H.; Hsu C. |
| 臺大學術典藏 |
2022-02-21T02:04:35Z |
Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
|
Hsu C.-L.; Ou D.-L.; Bai L.-Y.; Chen C.-W.; Lin L.; Huang S.-F.; ANN-LII CHENG; Jeng Y.-M.; Hsu C. |
| 臺大學術典藏 |
2022-02-21T02:04:34Z |
Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma
|
Shao Y.-Y.; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; Hsu C.; Hsu C.-H.; Hsu H.-C.; ANN-LII CHENG; Lin Z.-Z. |
| 臺大學術典藏 |
2022-02-21T02:04:33Z |
Dynamic contrast-enhanced and intravoxel incoherent motion mri biomarkers are correlated to survival outcome in advanced hepatocellular carcinoma
|
Chen B.-B.; Shao Y.-Y.; Lin Z.-Z.; Hsu C.-H.; ANN-LII CHENG; Hsu C.; Liang P.-C.; Shih T.T.-F. |
| 臺大學術典藏 |
2022-02-16T03:16:57Z |
Dynamic contrast-enhanced and intravoxel incoherent motion mri biomarkers are correlated to survival outcome in advanced hepatocellular carcinoma
|
Chen B.-B.; YU-YUN SHAO; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L.; Hsu C.; Liang P.-C.; Shih T.T.-F. |
| 臺大學術典藏 |
2022-02-16T03:16:57Z |
Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma
|
YU-YUN SHAO; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; Hsu C.; Hsu C.-H.; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z. |
| 臺大學術典藏 |
2022-02-16T03:16:56Z |
Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy
|
Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.; Hsu C.-H.; Lin Z.-Z.; YU-YUN SHAO; Lu L.-C.; Liu T.-H.; Chen C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-02-16T03:16:56Z |
Early changes in dce-mri biomarkers may predict survival outcomes in patients with advanced hepatocellular carcinoma after sorafenib failure: Two prospective phase ii trials
|
Chen B.-B.; Lin Z.-Z.; YU-YUN SHAO; Hsu C.; Hsu C.-H.; Cheng A.-L.; Liang P.-C.; Shih T.T.-F. |
| 臺大學術典藏 |
2022-02-14T07:10:49Z |
Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
|
Hsu C.-L.; Ou D.-L.; Bai L.-Y.; Chen C.-W.; Lin L.; Huang S.-F.; Cheng A.-L.; YUNG-MING JENG; Hsu C. |
| 臺大學術典藏 |
2022-02-14T07:10:49Z |
Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma
|
Shao Y.-Y.; Sun N.-Y.; YUNG-MING JENG; Wu Y.-M.; Hsu C.; Hsu C.-H.; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z. |
| 臺大學術典藏 |
2022-02-14T07:10:48Z |
Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy
|
Shen Y.-C.; Yeh C.-P.; YUNG-MING JENG; Hsu C.; Hsu C.-H.; Lin Z.-Z.; Shao Y.-Y.; Lu L.-C.; Liu T.-H.; Chen C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-02-08T06:27:20Z |
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|
DA-LIANG OU; Chen C.-W.; Hsu C.-L.; Chung C.-H.; Feng Z.-R.; Lee B.-S.; Cheng A.-L.; Yang M.-H.; Hsu C. |
| 臺大學術典藏 |
2022-02-08T06:27:19Z |
Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
|
Hsu C.-L.; DA-LIANG OU; Bai L.-Y.; Chen C.-W.; Lin L.; Huang S.-F.; Cheng A.-L.; Jeng Y.-M.; Hsu C. |
| 臺大學術典藏 |
2022-02-08T06:27:17Z |
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
|
Hsieh C.-H.; Jian C.-Z.; Lin L.-I.; Low G.-S.; Ou P.-Y.; Hsu C.; DA-LIANG OU |
| 臺大學術典藏 |
2022-02-07T03:29:06Z |
Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma
|
Hung Y.-P.; Shao Y.-Y.; Lee J.-M.; Hsu C.; CHIH-HUNG HSU; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2022-02-07T03:29:05Z |
The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma
|
Hung Y.-P.; Shao Y.-Y.; Hsu C.; CHIH-HUNG HSU; Lee J.-M.; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2022-02-07T03:29:05Z |
Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma
|
Shao Y.-Y.; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; Hsu C.; CHIH-HUNG HSU; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z. |
| 臺大學術典藏 |
2022-02-07T03:29:04Z |
Dynamic contrast-enhanced and intravoxel incoherent motion mri biomarkers are correlated to survival outcome in advanced hepatocellular carcinoma
|
Chen B.-B.; Shao Y.-Y.; Lin Z.-Z.; CHIH-HUNG HSU; Cheng A.-L.; Hsu C.; Liang P.-C.; Shih T.T.-F. |
| 臺大學術典藏 |
2022-02-07T03:29:03Z |
Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy
|
Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.; CHIH-HUNG HSU; Lin Z.-Z.; Shao Y.-Y.; Lu L.-C.; Liu T.-H.; Chen C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-02-07T03:29:03Z |
Early changes in dce-mri biomarkers may predict survival outcomes in patients with advanced hepatocellular carcinoma after sorafenib failure: Two prospective phase ii trials
|
Chen B.-B.; Lin Z.-Z.; Shao Y.-Y.; Hsu C.; CHIH-HUNG HSU; Cheng A.-L.; Liang P.-C.; Shih T.T.-F. |
| 臺大學術典藏 |
2022-01-24T09:30:58Z |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; Chen C.-H.; CHUN-JEN LIU; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group |
| 臺大學術典藏 |
2022-01-14T03:59:36Z |
Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers
|
JO-PAI CHEN; Lo Y.; Yu C.-J.; Hsu C.; Shih J.-Y.; Yang C.-H. |
| 臺大學術典藏 |
2022-01-05T03:36:36Z |
Spectrum of cancer patients receiving renal biopsy
|
Chang F.-C.; Chen T.W.-W.; Huang T.T.-M.; Lin W.-C.; Liu J.-S.; Chiang W.-C.; Chen Y.-M.; Hsu C.; KUN-HUEI YEH; Chu T.-S. |
| 臺大學術典藏 |
2022 |
Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma
|
Shao Y.-Y.; Cheng A.-L.; CHIH-HUNG HSU; Hsu C.; Lin Z.-Z.; Lu L.-C.; Chen B.-B.; Liang P.-C.; Shih T.T.-F.; Liu T.-H.; Shen Y.-C. |
| 國立成功大學 |
2022 |
Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma
|
Shao, Y.-Y.;Chen, P.-S.;Lin, Lin L.-I.;Lee, B.-S.;Ling, A.;Cheng, A.-L.;Hsu, C.;Ou, D.-L. |
| 臺大學術典藏 |
2021-12-22T03:53:47Z |
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
|
Ma H.; Campbell B.C.V.; Parsons M.W.; Churilov L.; Levi C.R.; Hsu C.; Kleinig T.J.; Wijeratne T.; Curtze S.; Dewey H.M.; Miteff F.; Tsai C.-H.; Lee J.-T.; Phan T.G.; Mahant N.; Sun M.-C.; Krause M.; Sturm J.; Grimley R.; Chen C.-H.; Hu C.-J.; Wong A.A.; Field D.; Sun Y.; Barber P.A.; Sabet A.; Jannes J.; JIANN-SHING JENG; Clissold B.; Markus R.; Lin C.-H.; Lien L.-M.; Bladin C.F.; Christensen S.; Yassi N.; Sharma G.; Bivard A.; Desmond P.M.; Yan B.; Mitchell P.J.; Thijs V.; Carey L.; Meretoja A.; Davis S.M.; Donnan G.A.; EXTEND Investigators, the EXTEND Investigators |
| 臺大學術典藏 |
2021-11-26T05:56:27Z |
Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data
|
Campbell B.C.V.; Ma H.; Ringleb P.A.; Parsons M.W.; Churilov L.; Bendszus M.; Levi C.R.; Hsu C.; Kleinig T.J.; Fatar M.; Leys D.; Molina C.; Wijeratne T.; Curtze S.; Dewey H.M.; Barber P.A.; Butcher K.S.; De Silva D.A.; Bladin C.F.; Yassi N.; Pfaff J.A.R.; Sharma G.; Bivard A.; Desmond P.M.; Schwab S.; Schellinger P.D.; Yan B.; Mitchell P.J.; Serena J.; Toni D.; Thijs V.; Hacke W.; Davis S.M.; Donnan G.A.; Davis S.M.; Desmond P.M.; Oxley T.; Wu T.Y.; Shah D.; Zhao H.; Rodrigues E.; Salvaris P.; Alemseged F.; Ng F.; Williams C.; Ng J.-L.; Tu H.T.-H.; McDonald A.; Jackson D.; Tsoleridis J.; McCoy R.; McCoy R.; Pesavento L.; Weir L.; Patel S.; Harvey J.; Mahadevan J.; Cheong E.; Balabanski A.; Waters M.; Drew R.; Cranefield J.; Mackey E.; Celestino S.; Low E.; Dewey H.M.; Loh P.S.; Choi P.M.; Coote S.; Frost T.; Hogan K.; Ding C.; McModie S.; Zhang W.W.; Kyndt C.; Moore A.; Ross Z.; Liu J.; Miteff F.; Levi C.R.; Ang T.; Spratt N.; Garcia-Esperon C.; Kaauwai L.; Phan T.G.; Ly J.; Singhal S.; Clissold B.; Wong K.; Krause M.; Day S.; Sturm J.; O'Brian B.; Grimley R.; Simpson M.; Lee-Archer M.; Brodtmann A.; Coulton B.; Young D.; Wong A.A.; Muller C.; Field D.K.; Vallat W.; Maxwell V.; Bailey P.; Sabet A.; Mishra S.; Tan M.; George K.; Barber P.A.; Zhao L.; Meretoja A.; Tatlisumak T.; Sibolt G.; Tiainen M.; Koivu M.; Aarnio K.; Virta J.; Kasari O.; Eirola S.; Sun M.C.; Chen T.C.; Chuang C.S.; Chen Y.Y.; Lin C.M.; Ho S.C.; Hsiao P.M.; Hsiao P.M.; Tsai C.H.; Huang W.S.; Yang Y.W.; Huang H.Y.; Wang W.C.; Liu C.H.; Lu M.K.; Lu C.H.; Kung W.L.; Jiang S.K.; Wu Y.H.; Huang S.C.; Tseng C.H.; Tseng L.T.; Guo Y.C.; Lin D.; Hsu C.T.; Kuan C.W.; Hsu J.P.; Tsai H.T.; Suzuki M.; Sun Y.; Chen H.F.; Lu C.J.; Lin C.H.; Huang C.C.; Chu H.J.; Lee C.Y.; Chang W.H.; Lo Y.C.; Hsu Y.T.; Chen C.H.; Sung P.S.; Ysai C.L.; Jeng J.S.; Tang S.C.; LI-KAI TSAI; Yeh S.J.; Lee Y.C.; Wang Y.T.; Chung T.C.; Hu C.J.; Chan L.; Chiou Y.W.; Lien L.M.; Yeh H.L.; Yeh J.H.; Chen W.H.; Lau C.L.; Chang A.; Lee I.Y.; Huang M.Y.; Lee J.T.; Peng G.S.; Lim J.C.; Hsu Y.D.; Lin C.C.; Cheng C.A.; Yen C.H.; Yang F.C.; Hsu C.H.; Sung Y.F.; Tsai C.K.; Tsai C.L.; Lee A.; Hankey G.; Blacker D.; Gerraty R.; Chen C.-I.; Hsu C.-S.; Cowley E.; Sallaberger M.; Snow B.; Kolbe J.; Stark R.; King J.; Macdonnell R.; Attia J.; D'Este C.; Bernhardt J.; Carey L.; Cadilhac D.; Anderson C.; Howells D.; Barber A.; Connelly A.; Macleod M.; O'Collins V.; Wilson W.; Macaulay L.; Bluhmki E.; Eschenfelder C.; Ringleb P.; Wahlgren N.; Wardlaw J.; Oppenheim C.; Lees K.R.; Kaste M.; von Kummer R.; Chatellier G.; Laage R.; Nu?ez X.; Ehrenkrona C.; Svenson A.-S.; Cove L.; Niederkorn K.; Gruber F.; Kapeller P.; Mikulik R.; Mas J.-L.; Berrouschot J.; Sobesky J.; K?hrmann M.; Steiner T.; Kessler C.; Dziewas R.; Poli S.; Althaus-Knaurer K.; Bovi P.; Rodriguez A.L.; Arenillas J.F.; Muir K.; Veltkamp R.; Dixit A.; Muddegowda G.; Kala L.; De Silva D.A.; Butcher K.S.; Byrnes G.; Peeters A.; Chalk J.B.; Fink J.N.; Kimber T.E.; Schultz D.; Hand P.J.; Frayne J.; Tress B.M.; McNeil J.; Burns R.; Johnston C.; Williams M.; EXTEND, ECASS-4, and EPITHET Investigators |
| 臺大學術典藏 |
2021-11-25T07:02:59Z |
Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data
|
Campbell B.C.V.; Ma H.; Ringleb P.A.; Parsons M.W.; Churilov L.; Bendszus M.; Levi C.R.; Hsu C.; Kleinig T.J.; Fatar M.; Leys D.; Molina C.; Wijeratne T.; Curtze S.; Dewey H.M.; Barber P.A.; Butcher K.S.; De Silva D.A.; Bladin C.F.; Yassi N.; Pfaff J.A.R.; Sharma G.; Bivard A.; Desmond P.M.; Schwab S.; Schellinger P.D.; Yan B.; Mitchell P.J.; Serena J.; Toni D.; Thijs V.; Hacke W.; Davis S.M.; Donnan G.A.; Davis S.M.; Desmond P.M.; Oxley T.; Wu T.Y.; Shah D.; Zhao H.; Rodrigues E.; Salvaris P.; Alemseged F.; Ng F.; Williams C.; Ng J.-L.; Tu H.T.-H.; McDonald A.; Jackson D.; Tsoleridis J.; McCoy R.; McCoy R.; Pesavento L.; Weir L.; Patel S.; Harvey J.; Mahadevan J.; Cheong E.; Balabanski A.; Waters M.; Drew R.; Cranefield J.; Mackey E.; Celestino S.; Low E.; Dewey H.M.; Loh P.S.; Choi P.M.; Coote S.; Frost T.; Hogan K.; Ding C.; McModie S.; Zhang W.W.; Kyndt C.; Moore A.; Ross Z.; Liu J.; Miteff F.; Levi C.R.; Ang T.; Spratt N.; Garcia-Esperon C.; Kaauwai L.; Phan T.G.; Ly J.; Singhal S.; Clissold B.; Wong K.; Krause M.; Day S.; Sturm J.; O'Brian B.; Grimley R.; Simpson M.; Lee-Archer M.; Brodtmann A.; Coulton B.; Young D.; Wong A.A.; Muller C.; Field D.K.; Vallat W.; Maxwell V.; Bailey P.; Sabet A.; Mishra S.; Tan M.; George K.; Barber P.A.; Zhao L.; Meretoja A.; Tatlisumak T.; Sibolt G.; Tiainen M.; Koivu M.; Aarnio K.; Virta J.; Kasari O.; Eirola S.; Sun M.C.; Chen T.C.; Chuang C.S.; Chen Y.Y.; Lin C.M.; Ho S.C.; Hsiao P.M.; Hsiao P.M.; Tsai C.H.; Huang W.S.; Yang Y.W.; Huang H.Y.; Wang W.C.; Liu C.H.; Lu M.K.; Lu C.H.; Kung W.L.; Jiang S.K.; Wu Y.H.; Huang S.C.; Tseng C.H.; Tseng L.T.; Guo Y.C.; Lin D.; Hsu C.T.; Kuan C.W.; Hsu J.P.; Tsai H.T.; Suzuki M.; Sun Y.; Chen H.F.; Lu C.J.; Lin C.H.; Huang C.C.; Chu H.J.; Lee C.Y.; Chang W.H.; Lo Y.C.; Hsu Y.T.; Chen C.H.; Sung P.S.; Ysai C.L.; Jeng J.S.; Tang S.C.; Tsai L.K.; SHIN-JOE YEH; Lee Y.C.; Wang Y.T.; Chung T.C.; Hu C.J.; Chan L.; Chiou Y.W.; Lien L.M.; Yeh H.L.; Yeh J.H.; Chen W.H.; Lau C.L.; Chang A.; Lee I.Y.; Huang M.Y.; Lee J.T.; Peng G.S.; Lim J.C.; Hsu Y.D.; Lin C.C.; Cheng C.A.; Yen C.H.; Yang F.C.; Hsu C.H.; Sung Y.F.; Tsai C.K.; Tsai C.L.; Lee A.; Hankey G.; Blacker D.; Gerraty R.; Chen C.-I.; Hsu C.-S.; Cowley E.; Sallaberger M.; Snow B.; Kolbe J.; Stark R.; King J.; Macdonnell R.; Attia J.; D'Este C.; Bernhardt J.; Carey L.; Cadilhac D.; Anderson C.; Howells D.; Barber A.; Connelly A.; Macleod M.; O'Collins V.; Wilson W.; Macaulay L.; Bluhmki E.; Eschenfelder C.; Ringleb P.; Wahlgren N.; Wardlaw J.; Oppenheim C.; Lees K.R.; Kaste M.; von Kummer R.; Chatellier G.; Laage R.; Nu?ez X.; Ehrenkrona C.; Svenson A.-S.; Cove L.; Niederkorn K.; Gruber F.; Kapeller P.; Mikulik R.; Mas J.-L.; Berrouschot J.; Sobesky J.; K?hrmann M.; Steiner T.; Kessler C.; Dziewas R.; Poli S.; Althaus-Knaurer K.; Bovi P.; Rodriguez A.L.; Arenillas J.F.; Muir K.; Veltkamp R.; Dixit A.; Muddegowda G.; Kala L.; De Silva D.A.; Butcher K.S.; Byrnes G.; Peeters A.; Chalk J.B.; Fink J.N.; Kimber T.E.; Schultz D.; Hand P.J.; Frayne J.; Tress B.M.; McNeil J.; Burns R.; Johnston C.; Williams M.; EXTEND, ECASS-4, and EPITHET Investigators |
| 臺大學術典藏 |
2021-10-06T08:04:49Z |
Critical Trio Exome Benefits In-Time Decision-Making for Pediatric Patients with Severe Illnesses?
|
Wu E.-T.; Hwu W.-L.; Chien Y.-H.; Hsu C.; Chen T.-F.; Chen N.-Q.; Chou H.-C.; Tsao P.-N.; Fan P.-C.; I-JUNG TSAI; Lin S.-P.; Hsieh W.-S.; Chang T.-M.; Chen C.-N.; Lee C.-H.; Chou Y.-Y.; Chiu P.-C.; Tsai W.-H.; Hsiung H.-C.; Lai F.; Lee N.-C. |
| 臺大學術典藏 |
2021-10-04T05:53:44Z |
Critical Trio Exome Benefits In-Time Decision-Making for Pediatric Patients with Severe Illnesses?
|
Wu E.-T.; Hwu W.-L.; Chien Y.-H.; Hsu C.; Chen T.-F.; Chen N.-Q.; Chou H.-C.; Tsao P.-N.; PI-CHUAN FAN; Tsai I.-J.; Lin S.-P.; Hsieh W.-S.; Chang T.-M.; Chen C.-N.; Lee C.-H.; Chou Y.-Y.; Chiu P.-C.; Tsai W.-H.; Hsiung H.-C.; Lai F.; Lee N.-C. |
| 國家衛生研究院 |
2021-10 |
Pathogenic role of specific macrophage and fibroblast subpopulations in acne keloidalis identified by single cell RNA sequencing
|
Hong, Y;Hwang, D;Yang, C;Cheng, S;Aala, W;Harn, H;Onoufriadis, A;Lu, KQ;McGrath, JA;Hsu, C |
| 臺大學術典藏 |
2021-09-15T01:20:53Z |
Development of a PD-L1-expressing orthotopic liver cancer model: Implications for immunotherapy for hepatocellular carcinoma
|
Ou D.-L.; Lin Y.-Y.; CHIA-LANG HSU; Lin Y.-Y.; Chen C.-W.; Yu J.-S.; Miaw S.-C.; Hsu P.-N.; Cheng A.-L.; Hsu C. |
| 臺大學術典藏 |
2021-09-15T01:20:46Z |
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|
Ou D.-L.; Chen C.-W.; CHIA-LANG HSU; Chung C.-H.; Feng Z.-R.; Lee B.-S.; Cheng A.-L.; Yang M.-H.; Hsu C. |
| 臺大學術典藏 |
2021-09-15T01:20:45Z |
Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
|
CHIA-LANG HSU; Ou D.-L.; Bai L.-Y.; Chen C.-W.; Lin L.; Huang S.-F.; Cheng A.-L.; Jeng Y.-M.; Hsu C. |
| 臺大學術典藏 |
2021-09-14T01:40:06Z |
Critical Trio Exome Benefits In-Time Decision-Making for Pediatric Patients with Severe Illnesses?
|
Wu E.-T.; Hwu W.-L.; Chien Y.-H.; Hsu C.; Chen T.-F.; Chen N.-Q.; Chou H.-C.; Tsao P.-N.; Fan P.-C.; Tsai I.-J.; Lin S.-P.; Hsieh W.-S.; Chang T.-M.; CHI-NIEN CHEN; Lee C.-H.; Chou Y.-Y.; Chiu P.-C.; Tsai W.-H.; Hsiung H.-C.; Lai F.; Lee N.-C. |
| 臺大學術典藏 |
2021-09-04T06:12:22Z |
Role of Viral Factors in Modifying Weight-Related Effects on Disease Progression of Chronic Hepatitis C Patients
|
Hsu C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-02T00:09:13Z |
Frequency and spectrum of actionable pathogenic secondary findings in Taiwanese exomes
|
Kuo C.-W;Hwu W.-L;Chien Y.-H;Hsu C;Hung M.-Z;Lin I.-L;Lai F;Lee N.-C.; Kuo C.-W; Hwu W.-L; Chien Y.-H; Hsu C; Hung M.-Z; Lin I.-L; Lai F; Lee N.-C.; FEI-PEI LAI |
| 臺大學術典藏 |
2021-09-02T00:05:17Z |
Collaborative Social-aware and QoE-driven Video Caching and Adaptation in Edge Network
|
Chiang Y;Hsu C;Wei H.; Chiang Y; Hsu C; Wei H.; HUNG-YU WEI |
| 臺大學術典藏 |
2021-09-01T02:02:40Z |
MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer
|
Hsu C.; Yeh K.-H.; Hong R.-L.; Yang C.-H.; Lin M.-T.; Chen Y.-C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:37Z |
Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL) - A very effective regimen with good patients' compliance for advanced gastric cancer
|
ANN-LII CHENG; Yeh K.-H.; Lin J.-T.; Hsu C.; Liu M.-Y. |
| 臺大學術典藏 |
2021-09-01T02:02:32Z |
Chemotherapy alone versus, surgery followed by chemotherapy for stage I/IIE large-cell lymphoma of the stomach
|
Liu H.-T.; Hsu C.; Chen C.-L.; Chiang I.-P.; Chen L.-T.; Chen Y.-C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:30Z |
Comparison of MALT and non-MALT primary large cell lymphoma of the stomach: Does histologic evidence of MALT affect chemotherapy response?
|
Hsu C.; Chen C.-L.; Chen L.-T.; Liu H.-T.; Chen Y.-C.; Jan C.-M.; Liu C.-S.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:28Z |
HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity
|
Hsu C.; Huang C.-L.; Hsu H.-C.; Lee P.-H.; Wang S.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:28Z |
Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer
|
Yang C.H.; Tsai C.M.; Wang L.S.; Lee Y.C.; Chang C.J.; Lui L.T.; Yen S.H.; Hsu C.; ANN-LII CHENG; Liu M.Y.; Chiang S.C.; Chen Y.M.; Luh K.T.; Huang M.H.; Yang P.-C.; Perng R.-P. |
| 臺大學術典藏 |
2021-09-01T02:02:26Z |
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
|
Hsu C.-H.; ANN-LII CHENG; Hsu C.; Yang C.-H.; Lu Y.-S.; Lin C.-C.; Bu C.-F.; Yeh K.-H. |
| 臺大學術典藏 |
2021-09-01T02:02:25Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Hsu C.; Huang C.-S.; Chao T.-Y.; Lu Y.-S.; Bu C.-F.; Chen M.M.; Chang K.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:23Z |
Survival-weighted health profile for long-term survivors of acute myelogenous leukemia
|
Hsu C.; Wang J.-D.; Hwang J.-S.; Tien H.-F.; Chang S.-M.; ANN-LII CHENG; Chen Y.-C.; Tang J.-L. |
| 臺大學術典藏 |
2021-09-01T02:02:22Z |
Low-dose thalidomide treatment for advanced hepatocellular carcinoma
|
Hsu C.; Chen C.-N.; Chen L.-T.; Wu C.-Y.; Yang P.-M.; Lai M.-Y.; Lee P.-H.; ANN-LII CHENG |
